A carregar...
An NKT-mediated autologous vaccine generates CD4 T-cell–dependent potent antilymphoma immunity
Relapses occurring in most patients with lymphoma after antibody or chemotherapy highlight a need for effective vaccination approaches. Autologous tumors are ideal sources of patient-specific tumor antigens for vaccines; however, their poor immunogenicity has been a major obstacle in practice. Natur...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society of Hematology
2007
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1976361/ https://ncbi.nlm.nih.gov/pubmed/17581919 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2006-12-061309 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|